| meta-analysis | Q815382 |
| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Irving Kirsch | Q2855713 |
| Markos Klonizakis | Q54837182 | ||
| Tania B Huedo-Medina | Q96241509 | ||
| P2093 | author name string | A Niroshan Siriwardena | |
| Jo Middlemass | |||
| P2860 | cites work | Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration | Q21092366 |
| Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy | Q23791313 | ||
| Fixed- versus random-effects models in meta-analysis: Model properties and an empirical comparison of differences in results | Q24273227 | ||
| Meta-analysis of benzodiazepine use in the treatment of insomnia | Q24534981 | ||
| Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits | Q24538295 | ||
| Magic bullets for insomnia? Patients' use and experiences of newer (Z drugs) versus older (benzodiazepine) hypnotics for sleep problems in primary care | Q24642656 | ||
| GPs' attitudes to benzodiazepine and 'Z-drug' prescribing: a barrier to implementation of evidence and guidance on hypnotics | Q24683948 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis | Q27860511 | ||
| Operating characteristics of a rank correlation test for publication bias | Q27860653 | ||
| Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860868 | ||
| Assessing the quality of reports of randomized clinical trials: is blinding necessary? | Q27860973 | ||
| A power primer | Q27861029 | ||
| Study of information submitted by drug companies to licensing authorities | Q28282248 | ||
| Assessing heterogeneity in meta-analysis: Q statistic or I2 index? | Q29619545 | ||
| How useful are unpublished data from the Food and Drug Administration in meta-analysis? | Q30769548 | ||
| Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis | Q31093217 | ||
| The socioeconomic impact of insomnia. An overview | Q33573309 | ||
| Hypnotics' association with mortality or cancer: a matched cohort study | Q34257362 | ||
| Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications | Q34534086 | ||
| The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. | Q34647579 | ||
| Scales to assess the quality of randomized controlled trials: a systematic review | Q34724144 | ||
| Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation | Q35802609 | ||
| A meta-analysis of sleep changes associated with placebo in hypnotic clinical trials. | Q40552459 | ||
| Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy | Q41673576 | ||
| Missing clinical trial data: setting the record straight | Q43595879 | ||
| Insomnia medication: Do published studies reflect the complete picture of efficacy and safety? | Q44917881 | ||
| Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs | Q47189246 | ||
| General practitioners' preferences for managing insomnia and opportunities for reducing hypnotic prescribing. | Q48354308 | ||
| Meta-analysis of sleep changes in control groups of insomnia treatment trials | Q48476654 | ||
| Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study | Q61912415 | ||
| Drug effects and initial severity of symptomatology | Q71158987 | ||
| The power of statistical tests for moderators in meta-analysis | Q81142643 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial | Q6936496 |
| P433 | issue | dec17 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| insomnia | Q1869874 | ||
| hypnotics and sedatives | Q50377192 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | e8343 | |
| P577 | publication date | 2012-12-17 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration | |
| P478 | volume | 345 |
| Q58118604 | A New Single-Item Sleep Quality Scale: Results of Psychometric Evaluation in Patients With Chronic Primary Insomnia and Depression |
| Q52592146 | A novel forehead temperature-regulating device for insomnia: a randomized clinical trial. |
| Q47615989 | Age, Sex, and Dose Effects of Nonbenzodiazepine Hypnotics on Hip Fracture in Nursing Home Residents. |
| Q47692821 | Aiding sleep in type 2 diabetes: therapeutic considerations |
| Q36153827 | An increased risk of reversible dementia may occur after zolpidem derivative use in the elderly population: a population-based case-control study |
| Q55135031 | Barriers and Facilitators to the Deprescribing of Nonbenzodiazepine Sedative Medications Among Older Adults. |
| Q37058023 | Benefits and risks of benzodiazepines and Z-drugs: comparison of perceptions of GPs and community pharmacists in Germany |
| Q39044821 | Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline |
| Q39048952 | Cognitive-behavioral therapy for insomnia in knee osteoarthritis: a randomized, double-blind, active placebo-controlled clinical trial |
| Q39138163 | Drug treatment of primary insomnia: a meta-analysis of polysomnographic randomized controlled trials |
| Q35615485 | Effect of Placebo Conditions on Polysomnographic Parameters in Primary Insomnia: A Meta-Analysis |
| Q60312781 | Effect of Traditional East Asian Medicinal herbal tea (HT002) on insomnia: a randomized controlled pilot study |
| Q34040228 | Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study |
| Q27333870 | Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial |
| Q24600118 | Efficacy of vestipitant, a neurokinin-1 receptor antagonist, in primary insomnia |
| Q47680110 | Eight-Year Follow-up of Hypnotic Delivery by Adults Aged 50 and Older from an Insurance Database |
| Q57283306 | Eszopiclone for insomnia |
| Q36518854 | Eszopiclone versus zopiclone in the treatment of insomnia |
| Q47628865 | European guideline for the diagnosis and treatment of insomnia |
| Q26866497 | How can placebo effects best be applied in clinical practice? A narrative review |
| Q38809491 | Identifying the Demographic and Mental Health Factors That Influence Insomnia Treatment Recommendations Within a Veteran Population |
| Q38781177 | Insomnia: the Sleeping Giant of Pediatric Public Health. |
| Q52681071 | Internet and In-Person Cognitive Behavioral Therapy for Insomnia in Military Personnel: A Randomized Clinical Trial. |
| Q55472563 | Long-term persistence of withdrawal of temazepam, zopiclone, and zolpidem in older adults: a 3-year follow-up study. |
| Q36048125 | Magnetic Resonance Spectroscopy in Patients with Insomnia: A Repeated Measurement Study |
| Q33887975 | Melatonin for sedative withdrawal in older patients with primary insomnia: a randomized double-blind placebo-controlled trial |
| Q36042579 | Multimorbidity and use of hypnotic and anxiolytic drugs: cross-sectional and follow-up study in primary healthcare in Iceland. |
| Q60046470 | Oral Delivered Dexmedetomidine Promotes and Consolidates Non-rapid Eye Movement Sleep via Sleep-Wake Regulation Systems in Mice |
| Q48116587 | Orexin receptor antagonists: a new treatment for insomnia? |
| Q36090682 | Patient Background Factors Affecting the Therapeutic Outcomes in Response to Eszopiclone in Adult Patients with Chronic Insomnia: A Post Hoc Analysis of a Double-Blind Phase III Study in Japan |
| Q60932103 | Patient Education and Pharmacist Consultation Influence on Nonbenzodiazepine Sedative Medication Deprescribing Success for Older Adults |
| Q39409071 | Patient Expectancy as a Mediator of Placebo Effects in Antidepressant Clinical Trials |
| Q35160989 | Persistent psychosis after abuse of high dose of zolpidem |
| Q38467876 | Pharmacokinetic and pharmacodynamic evaluation of ramelteon : an insomnia therapy |
| Q85358872 | Pharmacokinetics of zolpidem from sublingual zolpidem tartrate tablets in healthy elderly versus non-elderly subjects |
| Q36251904 | Pharmacological Treatment of Insomnia |
| Q37623240 | Primary care hypnotic and anxiolytic prescription: Reviewing prescribing practice over 8 years |
| Q35575395 | Quantifying the placebo effect in psychological outcomes of exercise training: a meta-analysis of randomized trials. |
| Q89184366 | Recent Advancements in Treating Sleep Disorders in Co-Occurring PTSD |
| Q33849413 | Residual effects of eszopiclone and placebo in healthy elderly subjects: a randomized double-blind study |
| Q65000615 | Responsiveness of Veterans Affairs Health Care System to Zolpidem Safety Warnings. |
| Q37322364 | Statistical Issues in TBI Clinical Studies |
| Q92145661 | Sublingual and oral zolpidem for insomnia disorder: a 3-month randomized trial |
| Q31113697 | Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials |
| Q39195007 | Systematic Review and Meta-analysis of Adolescent Cognitive-Behavioral Sleep Interventions. |
| Q47819498 | The Molecular Basis of Insomnia: Implication for Therapeutic Approaches |
| Q38220445 | The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: a systematic review and meta-analysis |
| Q64894936 | The acute effects of aerobic exercise on sleep in patients with depression: study protocol for a randomized controlled trial. |
| Q39758927 | The pattern of anxiolytic and hypnotic management by Australian general practice trainees |
| Q40496163 | Ultrasound guided injections of botulinum toxin type A into stellate ganglion to treat insomnia |
| Q38264419 | Use of ultra-low-dose (≤6 mg) doxepin for treatment of insomnia in older people |
| Q58572283 | Waking up to the problem of sleep: can mindfulness help? A review of theory and evidence for the effects of mindfulness for sleep |
| Q35997150 | Zolpidem use and risk of fractures: a systematic review and meta-analysis |
| Q87340117 | [Evolution of the use of antidepressants, anxiolytics and hypnotics in Valencia. Period 2000-2010] |
Search more.